Eyetas Therapeutics
About
Company description
Eyetas
Therapeutics was founded by Dr. Tassos Georgiou to revolutionize eye health
through science-driven innovation. With millions suffering from age-related macular
degeneration (AMD) and Stargardt’s disease, our mission is to address the unmet
needs in ophthalmology. Our team of leading scientists and healthcare experts
developed Eyetas, a pharmaceutical-grade Omega-3 supplement formulated with
highly purified EPA and DHA, essential for eye health.
Millions worldwide face vision loss from these conditions, yet few effective options exist. However, Eyetas offers a proactive approach, providing targeted nutritional support designed to preserve sight. By combining science and patient care, we are shaping the future of ophthalmology.
Clinical
and preclinical studies indicate promising results, reinforcing its potential
to maintain and improve vision. With a commitment to innovation, Eyetas
Therapeutics is redefining eye care by delivering research-backed solutions
that help protect vision where it’s needed most.
Discover how Eyetas
is bringing new hope to eye health.
Quick facts
| Sales markets | Africa; Eastern Europe; Western Europe |
|---|---|
| Primary business activity | Manufacturer: Finished Food Products |
| Affiliated categories: | Dietary supplements |Eye Health More |
